{
    "fund_name": "WisdomTree FTSE 100 3x Daily Short",
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": true,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "3x daily leverage",
        "Inverse exposure",
        "Synthetic replication using swaps",
        "Daily compounding effect",
        "Short-term trading focus",
        "High risk profile (7/7)",
        "Non-UCITS structure"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to multiple factors: 1) It uses 3x daily leverage, which creates significant volatility and compounding effects that are difficult for retail investors to understand. 2) The inverse exposure means returns move in the opposite direction of the underlying index, adding complexity. 3) The synthetic replication method relies on swap agreements, introducing counterparty risk. 4) The product is designed for short-term trading (1-day holding period) with a high risk profile (7/7). 5) It is not UCITS compliant, indicating a more complex structure. 6) The PRIIPs KID includes warnings about the product being 'not simple and may be difficult to understand', which is a direct MiFID II complexity indicator. 7) The fact sheet confirms the use of swaps and collateral management, which adds to the complexity. While the product is fully collateralized, the combination of these factors makes it unsuitable for retail investors without specialized knowledge.",
    "confidence": 95,
    "counter_argument": "One might argue that the full collateralization reduces risk, but this doesn't address the complexity of the leverage mechanics or the inverse nature of the product. The daily compounding effect and the need for active monitoring further support the complex classification.",
    "risk_level": "7/7 (highest risk)",
    "additional_notes": "The product's structure and risk profile clearly exceed the thresholds for complexity under MiFID II. The combination of leverage, inverse exposure, and synthetic replication creates a product that requires sophisticated understanding to assess risks appropriately. The high risk rating and non-UCITS status are further indicators of complexity."
}